Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,600
Closed -$2.67M 48
2022
Q3
$2.67M Buy
27,600
+800
+3% +$85.3K 0.09% 271
2022
Q2
$2.91M Buy
26,800
+12,400
+86% +$1.41M 0.11% 248
2022
Q1
$1.7M Sell
14,400
-20,200
-58% -$2.5M 0.06% 361
2021
Q4
$4.87M Buy
34,600
+15,700
+83% +$2.01M 0.17% 113
2021
Q3
$2.23M Sell
18,900
-1,700
-8% -$209K 0.07% 408
2021
Q2
$2.39M Buy
20,600
+10,800
+110% +$1.26M 0.08% 355
2021
Q1
$1.17M Buy
+9,800
New +$1.16M 0.04% 589

Other funds holding ABT

Point72 Hong Kong's ABT Position: Q2 2024 in Review

Point72 Hong Kong sold out of Abbott (ABT) in Q2 2024, closing a stake of 233,900 shares — an estimated $26.6M sold.

Point72 Hong Kong first reported a position in ABT in Q3 2014 and held it in 16 quarters. The position peaked at $26.6M in Q1 2024. 2,862 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

  • Point72 Hong Kong reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 233,900 Abbott shares in Q2 2024, an estimated $26.6M.
  • Point72 Hong Kong first reported a position in Abbott in Q3 2014 and held it in 16 quarters.
  • Point72 Hong Kong's Abbott position peaked at $26.6M in Q1 2024.
  • 2,862 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.